Showing results (171-180 of 185) with videos related to
Sort By:
Pageof 19
Bioengineering (Basel, Switzerland)|June 26, 2026
Toward More Translational Tumor Models: Breast dECM-Based 3D Systems Capture Native Microenvironmental CuesKatherine L Hebert, Jonathan J Savoie, Mackenzie L Hawes, et al.Stem Cells and Development|May 17, 2022
Breast Cancer-Stromal Interactions: Adipose-Derived Stromal/Stem Cell Age and Cancer Subtype Mediated RemodelingKatie M Hamel, Connor T King, Maryn B Cavalier, et al.BMC Cancer|March 9, 2019
Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft modelMargarite D Matossian, Hope E Burks, Steven Elliott, et al.Methods (San Diego, Calif.)|April 6, 2013
A new method for stranded whole transcriptome RNA-seqDavid F B Miller, Pearlly S Yan, Aaron Buechlein, et al.Frontiers in Bioscience (Landmark Edition)|June 24, 2022
Expression of Novel Kinase MAP3K19 in Various Cancers and Survival CorrelationsKhoa Nguyen, Hassan Yousefi, Thomas Cheng, et al.Breast Cancer Research and Treatment|July 1, 2021
NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cellsMargarite D Matossian, Steven Elliott, T Van Hoang, et al.International Journal of Environmental Research and Public Health|December 26, 2015
Glyceollin I Reverses Epithelial to Mesenchymal Transition in Letrozole Resistant Breast Cancer through ZEB1Patrick P Carriere, Shawn D Llopis, Anna C Naiki, et al.Journal of Cellular Biochemistry|April 20, 2021
Dual inhibition of MEK1/2 and MEK5 suppresses the EMT/migration axis in triple-negative breast cancer through FRA-1 regulationVan T Hoang, Margarite D Matossian, Jacqueline La, et al.Journal of Agricultural and Food Chemistry|December 12, 2024
Context-Dependent Estrogenic Actions of (+)-Pisatin Produced in Elicited Green or Snow Pea (Pisum sativum)Jorge A Belgodere, Megan C Benz, G Wills Kpeli, et al.Anti-Cancer Drugs|August 16, 2020
A novel screening approach comparing kinase activity of small molecule inhibitors with similar molecular structures and distinct biologic effects in triple-negative breast cancer to identify targetable signaling pathwaysMargarite D Matossian, Hope E Burks, Steven Elliott, et al.Pageof 19